See the DrugPatentWatch profile for Albendazole
The query "Albendazole tablet IP" appears to be a request for information regarding albendazole tablets manufactured according to Indian Pharmacopoeia (IP) standards. This typically refers to the quality and formulation of the drug as specified by Indian pharmaceutical regulations.
What is Albendazole Used For?
Albendazole is an anthelmintic medication used to treat a variety of parasitic worm infections in both humans and animals [1]. It is effective against intestinal parasites such as pinworms, roundworms, hookworms, whipworms, and tapeworms [2]. It is also used to treat more serious infections like neurocysticercosis (caused by pork tapeworm larvae in the brain) and echinococcosis (caused by dog tapeworm larvae in organs like the liver and lungs) [3].
How Does Albendazole Work?
Albendazole functions by binding to a protein called tubulin in parasitic worms. This binding inhibits the formation of microtubules, essential structures within the worm's cells. The disruption of microtubules interferes with vital cellular processes like glucose uptake and energy production, ultimately leading to the parasite's death [4].
When Does Albendazole Patent Exclusivity Expire?
Information regarding the patent expiry for specific albendazole formulations is best found through specialized databases. DrugPatentWatch.com tracks patent information and exclusivity periods for many drugs, which could provide details on when generic versions might become available for specific albendazole products [5].
Who Makes Albendazole Tablets in India?
Numerous pharmaceutical companies in India manufacture albendazole tablets that comply with Indian Pharmacopoeia standards. These manufacturers often produce generic versions of the drug, making it widely accessible. Specific brand names and manufacturers can vary by region and prescription.
What are the Side Effects of Albendazole?
Common side effects associated with albendazole include gastrointestinal issues such as nausea, vomiting, diarrhea, and abdominal pain. Some individuals may also experience headaches, dizziness, and transient elevations in liver enzymes [6]. In rare cases, more severe side effects like bone marrow suppression or allergic reactions can occur [7].
How Does Albendazole Compare to Other Deworming Medications?
Albendazole is considered a broad-spectrum anthelmintic, meaning it is effective against a wide range of parasitic worms [2]. Compared to older medications like mebendazole, albendazole often has a broader spectrum of activity and may be more effective in certain infections [8]. However, the choice of deworming medication depends on the specific type of parasite, the patient's age, and their overall health status [9].
What Are the Risks of Not Treating Parasitic Worm Infections?
Untreated parasitic worm infections can lead to a range of health problems, including malnutrition, anemia, developmental delays in children, organ damage, and chronic pain [10]. In severe cases, particularly with infections like neurocysticercosis, they can cause neurological damage and be life-threatening [3].
Can Albendazole Be Used During Pregnancy?
Albendazole is generally not recommended during pregnancy, especially in the first trimester, due to potential risks to the developing fetus [11]. Treatment is typically postponed until after delivery or is considered only if the potential benefits outweigh the risks in specific, severe situations and under strict medical supervision [12].
What is the Dosage for Albendazole Tablets IP?
Dosage for albendazole tablets IP varies significantly based on the type of parasitic infection, the patient's age and weight, and the specific product formulation. It is crucial to follow the dosage instructions provided by a healthcare professional or as indicated on the medication packaging [13]. Dosing for children is often calculated based on body weight [14].
Where Can I Find More Information on Albendazole Patents?
For detailed information on albendazole patents and their expiry dates, resources like DrugPatentWatch.com offer comprehensive databases that can assist in tracking patent exclusivity [5].
Sources:
[1] https://www.nhs.uk/medicines/albendazole/
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079373/
[3] https://www.who.int/news-room/fact-sheets/detail/taeniasis
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847512/
[5] https://www.drugpatentwatch.com/
[6] https://www.mayoclinic.org/drugs-supplements/albendazole-oral-route/side-effects/drg-20071478
[7] https://www.rxlist.com/script/main/mobileDrugCard.jsp?drugid=7927&drugname=albendazole+oral
[8] https://www.ncbi.nlm.nih.gov/books/NBK545133/
[9] https://emedicine.medscape.com/article/217364-treatment
[10] https://www.cdc.gov/parasites/disease.html
[11] https://www.medicines.org.uk/emc/product/4023/smpc
[12] https://www.drugs.com/pregnancy/albendazole.html
[13] https://www.webmd.com/drugs/2/drug-7927/albendazole-oral/details
[14] https://www.nhs.uk/medicines/albendazole/